New York, United States
Qure.ai is pioneering the use of Artificial Intelligence (AI) in the healthcare sector since its inception in 2016 with a singular mission: "Our mission is to make healthcare more affordable and accessible through the power of Artificial Intelligence." By integrating deep learning techniques, Qure.ai aims to make healthcare not only more accessible but also equitable across global landscapes.
The company has carved a niche in the identification and management of critical conditions, including Tuberculosis (TB), Lung Cancer, and Stroke. Its groundbreaking solutions not only aid clinicians directly but also drive advancements within the pharmaceutical and medical device industries by expediting diagnosis and facilitating proactive treatment planning.
Headquartered in the United States, Qure.ai recently secured a $65.00M Series D investment on June 25, 2024, led by Merck Global Health Innovation Fund. This strategic investment underscores confidence in Qure.ai's vision to enrich patient care globally through AI-driven healthcare innovations.
